نتایج جستجو برای: uplcpdaesimsn anticancer antioxidant

تعداد نتایج: 126758  

Journal: :ChemMedChem 2017
Barbara De Filippis Alessandra Ammazzalorso Marialuigia Fantacuzzi Letizia Giampietro Cristina Maccallini Rosa Amoroso

Stilbene is an abundant structural scaffold in nature, and stilbene-based compounds have been widely reported for their biological activity. Notably, (E)-resveratrol and its natural stilbene-containing derivatives have been extensively investigated as cardioprotective, potent antioxidant, anti-inflammatory, and anticancer agents. Starting from its potent chemotherapeutic activity against a wide...

2012
Mariappan Premanathan Srinivasan Radhakrishnan Kumarasamy Kulangiappar Ganesan Singaravelu Velayutham Thirumalaiarasu Thangavel Sivakumar Kandasamy Kathiresan

BACKGROUND & OBJECTIVES Derivatives of isatin are known to have cytotoxicity against human carcinoma cell lines. This compound therefore, has a potential to be used as a chemotherapeutic agent against cancer. This study was done to investigate the antioxidant and anticancer activities of isatin, extracted from flower of a folklore medicinal plant Couroupita guianensis against human promylocytic...

Journal: :Future Pharmacology 2022

Selenium is one of the eight necessary trace elements humans require for active health balance. It contributes in several ways to proper functioning selenoprotein. has received enormous interest recently due its therapeutic potential against a number ailments. To date, numerous chemical compounds containing selenium have been investigated therapy cancer and other disorders. Unifying atom into c...

Journal: :Bioinformation 2008
Kunal Jaiswal Pradeep Kumar Naik

This article describes a method developed for predicting anticancer/non-anticancer drugs using artificial neural network (ANN). The ANN used in this study is a feed-forward neural network with a standard back-propagation training algorithm. Using 30 'inductive' QSAR descriptors alone, we have been able to achieve 84.28% accuracy for correct separation of compounds with- and without anticancer a...

2017
Deme John Karikios Linda Mileshkin Andrew Martin Danielle Ferraro Martin R Stockler

OBJECTIVE Australia has a publicly funded universal healthcare system which heavily subsidises the cost of most registered anticancer drugs. The use of anticancer drugs that are unfunded, that is, not subsidised by the government, entails substantial out-of-pocket costs for patients. We sought to determine how frequently Australian medical oncologists discuss and prescribe unfunded anticancer d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید